Guidelines on the diagnosis and management of AL amyloidosis

This publication has 55 references indexed in Scilit:

• An overview of the use of high-dose melphalan with autologous stem cell transplantation for the treatment of AL amyloidosis
  Bone Marrow Transplantation, 2001
• Blood stem cell transplantation as therapy for primary systemic amyloidosis (AL)
  Bone Marrow Transplantation, 2000
• Prognostic factors for survival and response after high‐dose therapy and autologous stem cell transplantation in systemic AL amyloidosis: a report on 21 patients
  British Journal of Haematology, 1998
• VAD‐based regimens as primary treatment for multiple myeloma
  American Journal of Hematology, 1990
• INFUSION OF VINCRISTINE AND DOXORUBICIN WITH ORAL DEXAMETHASONE AS FIRST-LINE THERAPY FOR MULTIPLE MYELOMA
  The Lancet, 1989
• Resolution of Acquired Factor X Deficiency and Amyloidosis with Melphalan and Prednisone Therapy
  New England Journal of Medicine, 1987
• Response of Primary Hepatic Amyloidosis to Melphalan and Prednisone: A Case Report and Review of the Literature
  Mayo Clinic Proceedings, 1986
• Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents
  The American Journal of Cardiology, 1985
• Digoxin sensitivity in amyloid cardiomyopathy.
  Circulation, 1981
• Factor X Deficiency in Primary Amyloidosis
  New England Journal of Medicine, 1979